Rising NICU Demand Will Expand Future Maternal And Neonatal Services

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

28 May 25

AnalystConsensusTarget's Fair Value

US$16.71

1.1% overvalued

04 Sep

US$16.90

31.0%

5.0%

31.0%

5.0%

You can edit this narrative until May 28 8:10 PM. Then, changes will post as Updates.

Author's Valuation

US$16.711.1% overvalued

AnalystConsensusTarget Fair Value

Narrative

Updates0

AnalystConsensusTarget Fair Value

US$16.71

1.1% overvalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

2.69%

Healthcare Services revenue growth rate

0.23%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.78%

Calculation

US$145.07m

Earnings '28

12.34x

PE Ratio '28

US$1.79b

Market Cap '28

US$1.79b

Market Cap '28

88.03m

No. shares '28

US$20.34

Share Price '28

US$20.34 Share Price '28

Discounted to 2025 @ 6.78% p.a.

US$16.71

Fair Value '25